The use of alternative strategies for enhanced nanoparticle delivery to solid tumors

M Izci, C Maksoudian, BB Manshian… - Chemical …, 2021 - ACS Publications
Nanomaterial (NM) delivery to solid tumors has been the focus of intense research for over a
decade. Classically, scientists have tried to improve NM delivery by employing passive or …

Applications of nanobodies

S Muyldermans - Annual review of animal biosciences, 2021 - annualreviews.org
Unique, functional, homodimeric heavy chain–only antibodies, devoid of light chains, are
circulating in the blood of Camelidae. These antibodies recognize their cognate antigen via …

Method to diversify cyanine chromophore functionality enables improved biomolecule tracking and intracellular imaging

SM Usama, SC Marker, DH Li… - Journal of the …, 2023 - ACS Publications
Heptamethine indocyanines are invaluable probes for near-infrared (NIR) imaging. Despite
broad use, there are only a few synthetic methods to assemble these molecules, and each …

Nanobodies and nanobody-based human heavy chain antibodies as antitumor therapeutics

P Bannas, J Hambach, F Koch-Nolte - Frontiers in immunology, 2017 - frontiersin.org
Monoclonal antibodies have revolutionized cancer therapy. However, delivery to tumor cells
in vivo is hampered by the large size (150 kDa) of conventional antibodies. The minimal …

Nanobodies as therapeutics: big opportunities for small antibodies

S Steeland, RE Vandenbroucke, C Libert - Drug discovery today, 2016 - Elsevier
Highlights•Nanobodies (Nbs) are camelid-derived single-domain antibodies.•Nbs have
powerful binding and inhibitory capacity with great therapeutic potential.•Nbs are used in …

Nanobody: outstanding features for diagnostic and therapeutic applications

JP Salvador, L Vilaplana, MP Marco - Analytical and bioanalytical …, 2019 - Springer
Nanobodies (Nbs) have arisen as an alternative to conventional antibodies (Abs) and show
great potential when used as tools in different biotechnology fields such as diagnostics and …

[HTML][HTML] Molecular targeted therapy of cancer: The progress and future prospect

X Ke, L Shen - Frontiers in Laboratory Medicine, 2017 - Elsevier
Cancer has become a major public health problem worldwide. Researches focus on the
new approaches for cancer treatments that involve the specific targets of the cancer disease …

Exploiting nanobodies' singular traits

JR Ingram, FI Schmidt, HL Ploegh - Annual review of …, 2018 - annualreviews.org
The unique class of heavy chain–only antibodies, present in Camelidae, can be shrunk to
just the variable region of the heavy chain to yield VHHs, also called nanobodies. About one …

Nanobody-based cancer therapy of solid tumors

M Kijanka, B Dorresteijn, S Oliveira… - …, 2015 - Taylor & Francis
The development of tumor-targeted therapies using monoclonal antibodies has been
successful during the last 30 years. Nevertheless, the efficacy of antibody-based therapy is …

Single domain antibodies: promising experimental and therapeutic tools in infection and immunity

J Wesolowski, V Alzogaray, J Reyelt, M Unger… - Medical microbiology …, 2009 - Springer
Antibodies are important tools for experimental research and medical applications. Most
antibodies are composed of two heavy and two light chains. Both chains contribute to the …